Develops drugs for psoriasis and blood disorders.
Jun 2026Revenue $282M/yrExpenses $224M/yr
No trend
Figures by year
Is Protagonist Therapeutics profitable?
Yes. In the 12 months to Jun 2026, revenue was $282M and expenses $224M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $46.0M | $204M | −$158M |
| Dec 2024 | $434M | $182M | $253M |
| Dec 2023 | $60.0M | $154M | −$93.7M |
| Dec 2022 | $26.6M | $158M | −$131M |
| Dec 2021 | $27.4M | $153M | −$126M |
| Dec 2020 | $28.6M | $93.1M | −$64.5M |
| Dec 2019 | $231K | $80.8M | −$80.5M |
| Dec 2018 | $30.9M | $73.2M | −$42.3M |
| Dec 2017 | $20.1M | $58.0M | −$37.9M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.